Los Angeles Clinical Trials entered the industry of Medical Labs in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621511, which describes it as a Medical Labs. For further clarification, the SIC classifies this business under the code 8071 and described it as a Medical Labs. The business provides service to the B2C market.
To acquire more information, please contact Mitchell Nides by calling No number given during business hours. You can also write to the business’ Single Location at 2990 South Sepulveda Boulevard # 308, Los Angeles, California CA 90064. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Los Angeles Clinical Trials |
Representative: | Mitchell Nides |
Place of Business: | 2990 South Sepulveda Boulevard # 308, Los Angeles, CA 90064 |
Contact Number: | No number given |
Type of Service: | Medical Labs |
SIC Number: | 8071 |
NAICS Number: | 621511 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 2011 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Los Angeles Clinical Trials is a company operating from Los Angeles, California providing professional Medical Labs and relevant B2C variables. It was founded in 2011 and registered with the SIC code 8071 as Medical Labs, and with the NAICS code 621511 as Medical Labs.
With a current employee count of 1 to 4, Los Angeles Clinical Trials has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Mitchell Nides at No number given for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 2990 South Sepulveda Boulevard # 308 in Los Angeles, California 90064 and can be engaged online through the company website at , the company Twitter , and Facebook page .